Neo Ivy Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24,720
| Closed | -$1.08M | – | 485 |
|
|
2023
Q3 | $1.08M | Buy |
+24,720
| New | +$1.08M | 0.47% | 74 |
|
|
2022
Q4 | $85K | Buy |
+1,866
| New | +$85K | 0.06% | 266 |
|
|
2022
Q2 | – | Sell |
-3,612
| Closed | -$296K | – | 661 |
|
|
2022
Q1 | $296K | Buy |
+3,612
| New | +$296K | 0.27% | 141 |
|
|
2020
Q4 | – | Sell |
-562
| Closed | -$93K | – | 615 |
|
|
2020
Q3 | $93K | Buy |
+562
| New | +$93K | 0.09% | 298 |
|
|
2019
Q3 | – | Sell |
-8,554
| Closed | -$881K | – | 418 |
|
|
2019
Q2 | $881K | Buy |
+8,554
| New | +$881K | 0.5% | 84 |
|